RNA N^6-methyladenosine modification in cancers: current status and perspectives

查看全文 作　　者：Xiaolan [1,2,3]Deng;Rui [1,3]Su;Hengyou [1,3]Weng;Huilin [1,3]Huang;Zejuan [4]Li;Jianjun [1,3]Chen

机构地区：[1]Department of Systems Biology & the Gehr Family Center for Leukemia Research, The Beckman Research institute of City of Hope, Monrovia, CA 91016, USA;[2]School of Pharmacy, China Medical University, Shenyang 110122, China;[3]Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45219, USA;[4]Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA

出　　处：《Cell Research》索引2018年第28卷第5期,共11页

基　　金：This work was supported in part by a grant (No. 81603149 to X,D.) from National Nature Science Foundation of China, as well as the National Institutes of Health (NIH) R01 Grants CA214965 (J.C.), CA211614 (J.C.), and CA178454 (J.C.). Z.L. is supported by an American Cancer Society (ACS) Research Scholar Award. J.C. is a Leukemia & Lymphorna Society (LLS) Scholar. 关键词：RNA 癌症真核细胞生物功能蛋白质治疗学干细胞 DNA

相关文献

参考文献（104）
引证文献（79）
耦合文献（648）

参考文献(104)

引证文献(79)

耦合文献(648)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

RNA N^6-methyladenosine modification in cancers: current status and perspectives

参考文献(104)

引证文献(79)

耦合文献(648)

用户提示